PD-L1 Restrains the PD-1hiNrp1loTGFβ+ Treg to block IL6+ Neutrophil tumor infiltration to Suppress Inflammation-driven Colorectal Cancer

Dakota B. Poschel,John D. Klement,Alyssa D. Merting,Chunwan Lu,Yang Zhao,Dafeng Yang,Wei Xiao,Huabin Zhu,Ponnala Rajeshwari,Michael Toscano,Kimya Jones,Kiran Madwani,Amanda Barrett,Roni J. Bollag,Padraic G. Fallon,Huidong Shi,Kebin Liu

DOI: https://doi.org/10.1101/2023.10.12.562132

2023-01-01

Abstract:PD-L1 functions as a suppressor of T cell activation and colonic inflammation. The consequence of and mechanism underlying these opposite functions of PD-L1 in colorectal cancer remains unknown. We report that global Cd274 deletion promotes inflammation-driven colorectal tumorigenesis. 16S rRNA and shotgun metagenomic sequencing revealed that loss of host PD-L1 leads to expansion of gut Ligilactobacillus murinus and activation of the AhR pathway in tumor-bearing mice. scRNA-seq analysis revealed that PD-L1 regulates PD-189Nrp11215 Treg, IL6+ neutrophils, and B cells in colorectal tumor. Treg expresses high level of TGFβ to recruit IL6+ neutrophils. IL6 inhibits activation of B and T cells. IL6 blockade or B cell activation via CD40 agonist increases CTL activation and suppresses colon tumor growth in vivo. Our findings determine that PD-L1 functions as a tumor suppressor in the context of inflammation-driven colorectal cancer and the PD-L1/ L. murius /PD-189Nrp11215TGFβ+ Treg/IL6+ neutrophils pathway controls host cancer immunosurveillance and colorectal tumorigenesis. Key points Global deletion of Cd274 promotes inflammation-driven colorectal tumorigenesis. Loss of PD-L1 increases gut L. murinus and activates AhR pathway in colorectal tumor. PD-1hiTGFβ+Nrp1lo Treg recruits IL6+ neutrophils to inhibit B and T cell function in colorectal tumor. L. murinus and tryptophan metabolites connect PD-L1 and colorectal tumor immunosurveillance. ![Figure][1]</img> ### Competing Interest Statement The authors have declared no competing interest. [1]: pending:yes